Senator Elizabeth Warren introduced a bipartisan bill in June 2018 (S.3032) that would exempt most marijuana-related activities from the Controlled Substances Act when they are allowed under state or tribal law.
These data suggest that marijuana use, particularly non-medical use, is associated with poorer depression and anxiety outcomes in psychiatric patients.
Marijuana usage is increasing in adolescents, and the rate of comorbidity with mood and anxiety disorders is high. These findings may aid in identifying adolescents who are potentially at risk.
Users of synthetic marijuana products and health care providers should be aware of the risk of bleeding associated with contamination of synthetic cannabinoid products with brodifacoum.
Most US adults believe that marijuana has at least 1 benefit.
These data may be useful to clinicians in gaining insight on the potential risks of cannabis use among their patients with anxiety or mood disorders.
Across adult age categories, there was an increase in the prevalence of daily cannabis use after 2007.
The association of cannabis use with symptoms of psychosis underscores the need for targeted cannabis use prevention.
Cannabis use is associated with psychosis symptoms during adolescence.
Researchers emphasized the necessity of developing targeted interventions to address such health disparities among American Indian communities.
A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.
Patients who use medical marijuana may be more likely to use prescription drugs for both medical and nonmedical purposes.
These data may be helpful in titrating care for those with schizotypal disorder and comorbid substance abuse disorders to mitigate the risk for conversion to schizophrenia.
Mortality rates decreased for alcohol use disorders, self-harm, and interpersonal violence between 1980 and 2014. Mortality rates for drug use disorders increased both nationally and in each county over the same period.
The investigators found that antisocial (β=0.23) and borderline (β=0.20) personality disorders were strongly associated with cannabis use as well as with cannabis use disorder.
The findings of these analyses suggest that, to an extent, this relationship might be generalized to cannabis users as a whole, not just those diagnosed with a cannabis use disorder.
Online marijuana searches grew by 98 percent as a proportion of all searches from 2005 to 2017.
Researchers calculated age-standardized mortality rates on a county level in the United States between 1980 and 2014, specifically examining rates for self-harm, interpersonal violence, alcohol use, and drug use.
Both early-onset cannabis users and late-onset cannabis users had an increased risk for psychotic experiences at age 18.
Frequent cannabis use was associated with subsequent hypomania.
Cannabis use disorder is also rising faster in states that have legalized marjiuana.
The crystal structure may provide inspiration for designing drugs that refine efficacy and avoid adverse events.
Researchers find heavy users have lower bone density than cigarette smokers.
Δ9-Tetrahydrocannabinol (THC) is the main psychoactive chemical ingredient in cannabis.
One minute of exposure impaired endothelial function in rats for at least 90 minutes.
Marijuana-laced candy and baked goods are attractive to children, increasing calls to poison centers.
The increased use of synthetic cannabinoids presents a serious public health threat.
Alterations in reward processing may increase users' risk of continued drug use and subsequent addiction.
Chronic and severe cannabis-dependence is associated with deficits in striatal dopamine release.
Marijuana use is associated with development of various neuropsychiatric conditions such as schizophrenia, anxiety, and depression.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Age of Onset of Bipolar Disorder Linked With Substance Use Disorders
- Rapid Cycling in Bipolar Disorder: Overview and Expert Perspectives
- Low Testosterone Linked With Social Anxiety in Boys With Klinefelter Syndrome
- Posttraumatic Stress Disorder Associated With Reduced Brain Volume
- First-Episode Drug-Naive Patients With Schizophrenia More Likely to Attempt Suicide
- The Psychology of Hoarding Disorder: Approaches for Treatment
- Mind-Body Therapy and Psychiatry: Ancient Tools for Modern Practice
- Smartphone Applications for Depression and Anxiety: Are They Ready for Widespread Use?
- The Many Misconceptions of Catatonia: Treatment Is Often Successful With the Right Knowledge
- Marijuana Use Associated With Poorer Depression Outcomes, Increased Suicidal Ideation
- Healthcare Community Should Favor More Restrictive Alcohol Policies
- How to Respond to a Patient's Request for Prayer: A Clinician's Dilemma
- Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of Big Data
- ACA Coverage Gains Include Workers Without Insurance
- Steps Provided for Discharging Patients From Practice